MARTINSRIED, GERMANY -- (MARKET WIRE) -- December 11, 2006 -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today the successful completion of their novel RapMAT™ technology for faster antibody optimization. RapMATTM, which stands for "rapid maturation", improves the options for identifying antibodies from the HuCAL GOLD library and reduces the time for generation of promising lead molecules. The new technology has the potential to further improve MorphoSys's antibody engineering process in both of its business segments. The technology will be presented at the 17th IBC Antibody Engineering conference in San Diego, California.
